2022 Annual Meeting Virtual Experience | S3 - Abstracts of Distinction 3

Date Tuesday 04/26/22

Time 02:30 PM - 03:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Stefano Sandrone, PhD, Thomas Wychowski, MD

Topic(s) Global Health and Neuroepidemiology, Infectious Disease, Neuromuscular and Clinical Neurophysiology (EMG), Pain, Autonomic Disorders, Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Abstracts of distinction are top abstracts wihtin each topic presented in an oral format. Presentations are eight minutes in length with additional question and answer time during the session with the authors.

CME Available 1.00 CME credit

Program Materials Program Evaluations

Event Timeline
02:30 PM - 02:38 PM EDT	Speaker	Fast Progression in Amyotrophic Lateral Sclerosis: Pathways and Biomarkers from Multi-Omics Analysis Roland G. Huber, PhD
02:38 PM - 02:46 PM EDT	Speaker	Autonomic dysfunction following COVID-19 infection: an early experience Kamal Shouman, MD
02:46 PM - 02:54 PM EDT	Speaker	Meta-analysis of 175 Patients with COVID-19 and Seizures, Status Epilepticus, or Cortical Myoclonus: An Individual Patient Data Analysis Cristina Jageka, MD
02:54 PM - 03:00 PM EDT	Q&A	Q&A Cristina Jageka, MD, Roland G. Huber, PhD, Kamal Shouman, MD
03:00 PM - 03:08 PM EDT	Speaker	Socioeconomic Status and Cognitive Function in Children with HIV: Evidence from the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study Esau G. Mbewe
03:08 PM - 03:16 PM EDT	Speaker	Clinical Characteristics and Outcomes of Neuroinvasive West Nile Virus Infection in Immunosuppressed and Immunocompetent Individuals Treated at the Mayo Clinic Hospitals David Gritsch, MD, PhD
03:16 PM - 03:24 PM EDT	Speaker	Durability of 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy: 18-Month Multicenter Randomized Controlled Trial Results Erika Petersen, MD
03:24 PM - 03:30 PM EDT	Q&A	Q&A Esau G. Mbewe, Erika Petersen, MD, David Gritsch, MD, PhD

Faculty Disclosures
Roland G. Huber, PhD	Dr. Huber has received intellectual property interests from a discovery or technology relating to health care.
Kamal Shouman, MD	The institution of Dr. Shouman has received research support from dysautonomia international.
Cristina Jageka, MD	Miss Jageka has nothing to disclose.
Esau G. Mbewe	Esau G. Mbewe has received research support from Research was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS117310. .
David Gritsch, MD, PhD	Dr. Gritsch has nothing to disclose.
Erika Petersen, MD	Erika Petersen, MD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Nevro. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott Neuromodulation. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Erika Petersen, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertos. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Saluda. Erika Petersen, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Pain and Neurosciences. Erika Petersen, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SynerFuse. Erika Petersen, MD has stock in SynerFuse. Erika Petersen, MD has stock in neuro.42. The institution of Erika Petersen, MD has received research support from Saluda. The institution of Erika Petersen, MD has received research support from Nevro. The institution of Erika Petersen, MD has received research support from ReNeuron. The institution of Erika Petersen, MD has received research support from Neuros. Erika Petersen, MD has received intellectual property interests from a discovery or technology relating to health care.
Thomas Wychowski, MD	Dr. Wychowski has nothing to disclose.
Stefano Sandrone, PhD	Dr. Sandrone has nothing to disclose.